carvedilol phosphate

The phosphate salt form of carvedilol, a racemic mixture and adrenergic blocking agent with antihypertensive activity and devoid of intrinsic… (More)
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Carvedilol is a non-selective adrenergic antagonist with no intrinsic sympathomimetic activity widely used to treat essential… (More)
  • table 1
  • table 2
  • figure 1
  • table 3
  • table 4
Is this relevant?
2014
2014
The objective of the study was to enhance the solubility of carvedilol phosphate and to formulate it into non-effervescent… (More)
  • table I
  • table II
  • table III
  • figure 1
  • figure 2
Is this relevant?
2012
2012
OBJECTIVES To compare adherence between once-daily (QD) and twice-daily (BID) dosing with chronic-use prescription medications… (More)
Is this relevant?
2012
2012
Purpose: To evaluate the effect of two molecular weight grades of hydroxypropyl methylcellulose on the release characteristics of… (More)
  • table 1
  • figure 2
  • figure 1
  • figure 3
  • table 2
Is this relevant?
2012
2012
A simple, sensitive and accurate UV spectrophotometric method has been developed for the determination of carvedilol phosphate in… (More)
  • table 2
  • figure 3
Is this relevant?
2011
2011
UNLABELLED A 3(2) full factorial design was employed for the formulation and characterization of an expandable, gastroretentive… (More)
Is this relevant?
2011
2011
β-adrenergic blocking agents have been in use for nearly 40 years. β-blockers have been more thoroughly studied in the past… (More)
Is this relevant?
2010
2010
Carvedilol, a non selective β blocking drug under the biopharmaceutical classification system (BCS) class II, is widely used in… (More)
  • table 1
  • table 2
  • figure 1
  • table 3
  • figure 2
Is this relevant?
2009
2009
The effect of surfactants on the solubility of a new phosphate salt of carvedilol was investigated at different biorelevent pH to… (More)
  • figure 2
  • figure 3
  • figure 1
  • figure 4
  • figure 6
Is this relevant?
2009
2009
BACKGROUND Suboptimal compliance in taking guideline-based pharmacotherapy in patients with chronic heart failure (HF… (More)
Is this relevant?